Gavilimomab
加维莫单抗
Report date: 2023/04/25 13:51:01
Base Information
Drug NameGavilimomab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbgenix Incorporated
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesGenzyme CorpAbgenix Incorporated
Active IndicationsN/A
Inactive Indications +[4]